InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
16
T+90 hit rate
11%
T+90 mean return
-21.8%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Kumar Neil, Chief Executive Officer. Officer active across 1 company, notably BridgeBio Pharma, Inc.. Cumulatively, 38 reports have been recorded. Breakdown: 0 buy · 16 sells. Total volume traded: €26m. History available since 5 January 2023. The latest transaction was filed on 21 May 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations38 total
2,256 shares@ US$67.56870.0009% mcap0.5% of flowCommon StockSEC:0001470831-26-000488:0
6,725 shares@ US$68.30250.0027% mcap1.5% of flowCommon StockSEC:0001470831-26-000488:1
5,072 shares@ US$69.22350.0020% mcap1.2% of flowCommon StockSEC:0001470831-26-000488:2
11,250 shares@ US$70.48140.0046% mcap2.6% of flowCommon StockSEC:0001470831-26-000488:3
800 shares@ US$70.91890.0003% mcap0.2% of flowCommon StockSEC:0001470831-26-000488:4
64,696 sharesCommon StockSEC:0000950170-25-075425:0
75,000 shares@ US$34.1078.7% of flowCommon StockSEC:0000950170-25-058102:0
75,000 shares@ US$36.86599.8% of flowCommon StockSEC:0000950170-25-046171:0
37,899 shares@ US$33.36364.6% of flowCommon StockSEC:0000950170-25-029228:0
55,539 sharesCommon StockSEC:0000950170-25-023625:0
326,932 shares@ US$36.28743.6% of flowCommon StockSEC:0000950170-25-011239:0
4,685,725 shares0Common StockSEC:0000950170-24-140871:0
25,514 shares@ US$22.38562.1% of flowCommon StockSEC:0000950170-24-129455:0
55,537 sharesCommon StockSEC:0000950170-24-128910:0
55,537 sharesCommon StockSEC:0000950170-24-099275:0
60,667 sharesCommon StockSEC:0000950170-24-061646:0
102,249 sharesCommon StockSEC:0000950170-24-017891:0
102,249 sharesCommon StockSEC:0001209191-23-056012:0
102,250 sharesCommon StockSEC:0001209191-23-046511:0
102,249 sharesCommon StockSEC:0001209191-23-030599:0
120,000 shares@ US$14.18125.9% of flowCommon StockSEC:0001209191-23-027630:0
120,000 shares@ US$15.46386.5% of flowCommon StockSEC:0001209191-23-023803:0
120,000 shares@ US$10.96024.8% of flowCommon StockSEC:0001209191-23-016059:0
68,706 sharesCommon StockSEC:0001209191-23-011447:0
120,000 shares@ US$11.00584.7% of flowCommon StockSEC:0001209191-23-007376:0
25 of 38 declarations
About Kumar Neil
Neil Kumar is CEO and President of BridgeBio Pharma, Inc. In this role, he is responsible for the strategic and operational leadership of the company. Neil plays a key role in defining growth objectives and optimizing performance. His leadership is essential for ensuring the long-term success of BridgeBio.
